Acne behind the ears can be frustrating and uncomfortable but understanding its causes and how to treat it can help ...

A combination of nicotinamide (750 mg), zinc oxide (25 mg), and folic acid (500 µg) is approved for the treatment of acne vulgaris (and rosacea). Both nicotinamide and zinc oxide have anti ...

Patients should be informed that currently available light treatments are not recommended amongst first-line treatments for acne vulgaris, and that long-term safety data in acne are as yet unknown.

They can rule out possible hyperandrogenism (androgen sex hormone condition). Related: What Is Acne Vulgaris? Acne caused by sex hormone changes during puberty (hormonal acne) is most common in ...

This new product is bioequivalent and therapeutically equivalent to the reference-listed drug, Evoclin Foam, 1%, manufactured ...

Dublin, Ireland and Mumbai, India and London, United Kingdom--( - February 10, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a ...

Egypt: A recent systematic review and meta-analysis evaluating the efficacy and safety of spironolactone in patients with acne vulgaris suggests that the drug significantly improves acne ...

Glenmark Pharmaceuticals and Ireland-based Cosmo Pharmaceuticals NV have received approval from the Medicines and Healthcare ...

Glenmark Pharmaceuticals and Cosmo Pharmaceuticals have received approval from the MHRA for marketing Winlevi, an acne treatment, in the UK. The product, which targets patients aged 12 and older, ...

Glenmark Pharmaceuticals Ltd, in collaboration with Cosmo Pharmaceuticals N.V., has received approval from the UK Medicines ...